Abbott Sustainability Profile
Abbott Laboratories, commonly known as Abbott, is a leading global healthcare company headquartered in the United States. Founded in 1888, Abbott has established a strong presence in various operational regions, including North America, Europe, and Asia. The company operates primarily in the medical devices, diagnostics, nutrition, and pharmaceuticals sectors. Abbott is renowned for its innovative products, such as the FreeStyle Libre glucose monitoring system and Similac infant formula, which set industry standards for quality and effectiveness. With a commitment to advancing health and well-being, Abbott has achieved significant milestones, including the rapid development of COVID-19 testing solutions. As a market leader, Abbott consistently ranks among the top healthcare companies worldwide, recognised for its dedication to research and development, and its ability to deliver cutting-edge solutions that improve patient outcomes.
DitchCarbon Score
How does Abbott's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Abbott's score of 67 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Abbott's reported carbon emissions
In 2024, Abbott reported total carbon emissions of approximately 1,894,000,000 kg CO2e globally. This includes 502,000,000 kg CO2e from Scope 1 emissions, primarily from stationary combustion, and 393,000,000 kg CO2e from Scope 2 emissions (market-based). The company also disclosed significant Scope 3 emissions, amounting to about 7,056,000,000 kg CO2e, with the largest contributions from purchased goods and services (approximately 7,056,000,000 kg CO2e) and upstream transportation and distribution (about 1,236,000,000 kg CO2e). Abbott has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 emissions by 30% by 2030, using 2018 as the baseline. This target aligns with the Science Based Targets initiative (SBTi) and is part of a broader strategy to achieve net-zero emissions by 2050. The company also commits that 82% of its suppliers, covering purchased goods and services and upstream transportation and distribution, will have science-based targets by 2026. In the UK, Abbott reported total emissions of approximately 10,368,000 kg CO2e for 2023, with Scope 1 emissions at about 499,000 kg CO2e and Scope 2 emissions at approximately 8,000,000 kg CO2e (market-based). The Scope 3 emissions for the same year were around 9,543,000 kg CO2e. Overall, Abbott's climate strategy reflects a strong commitment to reducing its carbon footprint and engaging its supply chain in sustainability efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 578,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 691,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - | - | - | - | 0,000,000,000 |
How Carbon Intensive is Abbott's Industry?
How Carbon Intensive is Abbott's Location?
Abbott's Scope 3 Categories Breakdown
The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 71% of Scope 3 emissions.
Top Scope 3 Categories
Abbott's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Abbott has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
GlaxoSmithKline Pharmaceuticals Limited
Siemens Healthineers AG
Frequently Asked Questions
Common questions about Abbott's sustainability data and climate commitments